These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34269742)

  • 1. The effects of the COVID-19 pandemic on the treatment of allergic eye diseases.
    Leonardi A; Salami E; Feuerman OM; Cavarzeran F
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):500-506. PubMed ID: 34269742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vernal keratoconjunctivitis: An update.
    Ghiglioni DG; Zicari AM; Parisi GF; Marchese G; Indolfi C; Diaferio L; Brindisi G; Ciprandi G; Marseglia GL; Miraglia Del Giudice M
    Eur J Ophthalmol; 2021 Nov; 31(6):2828-2842. PubMed ID: 34058899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus for allergic eye diseases.
    Erdinest N; Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):535-543. PubMed ID: 31169598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
    Bielory L; Katelaris CH; Lightman S; Naclerio RM
    MedGenMed; 2007 Aug; 9(3):35. PubMed ID: 18092041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.
    Fujishima H; Okada N; Matsumoto K; Fukagawa K; Igarashi A; Matsuda A; Ono J; Ohta S; Mukai H; Yoshikawa M; Izuhara K
    J Allergy Clin Immunol; 2016 Aug; 138(2):459-467.e2. PubMed ID: 26964692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.
    Kim SE; Nowak V; Quartilho A; Larkin F; Hingorani M; Tuft S; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013298. PubMed ID: 33084033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of ocular allergy in Thai children.
    Jongvanitpak R; Vichyanond P; Jirapongsananuruk O; Visitsunthorn N; Pacharn P
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):407-413. PubMed ID: 32061246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
    Uchio E; Ono SY; Ikezawa Z; Ohno S
    Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic conjunctivitis: current concepts on pathogenesis and management.
    Sacchetti M; Abicca I; Bruscolini A; Cavaliere C; Nebbioso M; Lambiase A
    J Biol Regul Homeost Agents; 2018; 32(1 Suppl. 1):49-60. PubMed ID: 29552874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
    Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis.
    Fernandez A; Asbell P; Roy N
    Ocul Surf; 2022 Oct; 26():191-196. PubMed ID: 35970432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
    Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
    Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Leonardi A; Righetti G; Giovannini G; De Marchi V; Occhiuto M
    Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):390-396. PubMed ID: 37284778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergy and the eye.
    Leonardi A; Motterle L; Bortolotti M
    Clin Exp Immunol; 2008 Sep; 153 Suppl 1(Suppl 1):17-21. PubMed ID: 18721324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.